Peter Saltonstall of NORD Discusses Drug Pricing Challenges

Peter Saltonstall, President and Chief Executive Officer of the National Organization for Rare Disorders (NORD) discusses some of the challenges facing the rare disease community, including the perception that drug pricing for orphan drugs is a driving force behind rising drug prices.

Becky Abbott of NFED on Why She Attends Rare Disease Week

Becky Abbott, MPH, Manager of Treatment and Research at the National Foundation for Ectodermal Dysplasias (NFED) discuses why she attends Rare Disease Week. Ectodermal dysplasias (ED), a group of more than 180 disorders that affect the outer layer of tissue of the...

The National Foundation for Ectodermal Dysplasias (NFED)

Becky Abbott, MPH, Manager of Treatment and Research at the National Foundation for Ectodermal Dysplasias (NFED) discuses her organization and ectodermal dysplasias (ED), a group of more than 180 disorders that affect the outer layer of tissue of the embryo (ectoderm) that helps make up the skin, sweat glands, hair, teeth, and nails.

Benamin Forred Discusses Rare Disease Day

Benjamin Forred, Translational Research Project Manager at Sanford Health in Sioux Falls, South Dakota, discusses Rare Disease Day and his organization which is one of the largest health systems in the United States, including research into rare diseases.

  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.